The FDA has approved personalized cellular therapy, a first-of-its kind cancer breakthrough, created here at Penn Medicine.
The Varian Halcyon™ system works at twice the speed of other radiation technologies, shortening the amount of time patients spend undergoing each treatment session.
The FDA has approved a personalized cellular therapy — the first of its kind — created at Penn Medicine for pediatric and young adult leukemia. Read our press release or call 215-316-5127 for more information.
We are thrilled to welcome renowned surgical oncologist, Ronald DeMatteo, MD, FACS, as Chair of the Department of Surgery.
We are ranked #1 in the Philadelphia region and 7th in the nation for cancer care by U.S. News & World Report.
Clinical trials help cancer survivors live longer and have a better quality of life through new ways to detect, diagnose and treat cancer.
Proton therapy is a non–invasive, incredibly precise cancer treatment that uses a beam of protons moving at very high speeds to destroy cancer cells.
Our experienced cancer nurses and referral staff are here to help. Call 800-789-7366 (PENN) or complete an online request.
Learn more about the benefits of translational research at Penn Medicine.